Page last updated: 2024-08-24

gemcitabine and 1-palmitoyl-2-linoleoyl-3-acetyl-rac glycerol

gemcitabine has been researched along with 1-palmitoyl-2-linoleoyl-3-acetyl-rac glycerol in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chong, S; Han, YH; Kim, HJ; Kim, JW; Kim, MH; Lee, HR; Shin, SH; Sohn, KY; Yoo, N; Yoon, SY1

Other Studies

1 other study(ies) available for gemcitabine and 1-palmitoyl-2-linoleoyl-3-acetyl-rac glycerol

ArticleYear
PLAG (1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol) augments the therapeutic effect of pegfilgrastim on gemcitabine-induced neutropenia.
    Cancer letters, 2016, 07-10, Volume: 377, Issue:1

    Topics: Animals; Biomarkers; Cell Movement; Deoxycytidine; Diglycerides; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Filgrastim; Gemcitabine; Granulocyte Colony-Stimulating Factor; Leukocyte Count; Mice, Inbred BALB C; Neutropenia; Neutrophils; Polyethylene Glycols; Receptors, Interleukin-8B; Recombinant Proteins; Time Factors

2016